US Patent Issued to GI BIOME, MEDIOGEN on Nov. 18 for "Lactobacillus helveticus strain and composition containing same for prevention or treatment of inflammatory diseases" (South Korean Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,472,215, issued on Nov. 18, was assigned to GI BIOME (Seongnam-si, South Korea) and MEDIOGEN Co. LTD. (Jecheon-si, South Korea).

"Lactobacillus helveticus strain and composition containing same for prevention or treatment of inflammatory diseases" was invented by Bo Gie Yang (Seoul, South Korea), Myung Ho Jang (Seoul, South Korea), Chang Ho Kang (Chungju-si, South Korea) and Nam Soo Paek (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a Lactobacillus helveticus strain and a composition for preventing or treating inflammatory disease containing the same. The Lactobacillus helveticus strain (Accession No. KCTC 14110BP) acco...